Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bacteremia/drug therapy/microbiology"'
Publikováno v:
Clinical Infectious Diseases, Vol. 44, No 1 (2007) pp. 87-93
Inadequate antibiotic therapy, generally defined as microbiologically ineffective anti-infective therapy against the causative pathogen, can influence patient outcome. However, the detrimental effects of inadequate antibiotic therapy seem to become w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::74de5819383fbc8ce2a271a019e17961
http://doc.rero.ch/record/291702/files/44-1-87.pdf
http://doc.rero.ch/record/291702/files/44-1-87.pdf
Autor:
Heidi, Ammerlaan, Harald, Seifert, Stephan, Harbarth, Christian, Brun-Buisson, Antoni, Torres, Massimo, Antonelli, Jan, Kluytmans, Marc, Bonten, O M, Williams
Publikováno v:
Clinical Infectious Diseases, Vol. 49, No 7 (2009) pp. 997-1005
Clinical Infectious Diseases, 49(7), 997-1005. Oxford University Press
Ammerlaan, H, Seifert, H, Harbarth, S, Brun-Buisson, C, Torres, A, Antonelli, M, Kluijtmans, J A J W & Bonten, MJ 2009, ' Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries ', Clinical Infectious Diseases, vol. 49, no. 7, pp. 997-1005 . https://doi.org/10.1086/605555
Clinical Infectious Diseases, 49(7), 997-1005. Oxford University Press
Ammerlaan, H, Seifert, H, Harbarth, S, Brun-Buisson, C, Torres, A, Antonelli, M, Kluijtmans, J A J W & Bonten, MJ 2009, ' Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries ', Clinical Infectious Diseases, vol. 49, no. 7, pp. 997-1005 . https://doi.org/10.1086/605555
BACKGROUND: Little is known about the incidence of inadequate treatment of severe Staphylococcus aureus infection in Europe. We aimed to evaluate the adequacy of antibiotic therapy for S. aureus bacteremia (SAB), to identify determinants of inadequat
Staphylococcus aureus small colony variants (SCVs) are associated with chronic and persistent infections. Methicillin-resistant S. aureus (MRSA) SCVs cause more severe infections and mortality rates are higher in comparison with infections caused by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b0bc11199792dc2606dc7644ba1de4
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/9337
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/9337
Autor:
Christian van Delden
Publikováno v:
International Journal of Antimicrobial Agents, Vol. 30, No Suppl 1 (2007) pp. S71-75
Pseudomonas aeruginosa remains a major cause of bloodstream infections associated with high mortality. Adequacy of empirical therapy seems to influence outcome. Because of its high intrinsic resistance and its capacity to develop resistance during th
Autor:
Louis Bernard, Patrice Francois, Daniel Pablo Lew, Jacques Schrenzel, Adriana Renzoni, Marta Buzzi, Stéphan Juergen Harbarth, Pierre Vaudaux, Tristan Ferry, Elzbieta Huggler, Ilker Uçkay
Publikováno v:
Antimicrobial Agents and Chemotherapy, Vol. 56, No 3 (2012) pp. 1258-64
Antimicrobial agents and chemotherapy
Antimicrobial agents and chemotherapy
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates is considered a risk factor for failure of glycopeptide therapy. We compared the prevalences of MRSA isolates with reduced glycopeptide su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25afb08dba1d5f3766fb2b2403ade32d
https://archive-ouverte.unige.ch/unige:25168
https://archive-ouverte.unige.ch/unige:25168
Publikováno v:
The Journal of infection. 48(2)
Motile Enterococci are rare causes of enterococcal bacteremia, usually in immunocompromised patients. We describe a case of polymicrobial bacteremia, including Enterococcus casseliflavus, Escherichia coli, and Morganella morganii, in an 80-year old w
Publikováno v:
Archives of Internal Medicine, Vol. 158, No 2 (1998) pp. 182-189
BACKGROUND: Uncertainties remain about the contribution of methicillin resistance to morbidity and mortality associated with bacteremia caused by Staphylococcus aureus. OBJECTIVE: To assess the impact of methicillin resistance on patient outcome afte